Advertisement

Pharmaceutisch Weekblad

, Volume 9, Supplement 1, pp S60–S63 | Cite as

Treatment of acute exacerbations of chronic bronchitis with ciprofloxacin

  • J. A. A. Hoogkamp-Korstange
  • S. J. Klein
Article

Abstract

Thirty four patients with acute purulent exacerbations of chronic bronchitis were treated with 500 mg ciprofloxacin twice daily, orally, for ten days. Short time cure rate was 97% (cure 71%, improvement 26%) and failure 3%, long time cure rate (six months follow-up) was 74%. Predominant initial pathogens wereHaemophilus influenzae andStreptococcus pneumoniae, mostly in pure cultures. All sputum cultures except those withStreptococcus pneumoniae became negative on the third day of treatment. Apart from a slower clearance of pneumococci from sputum there were no significant differences in responses between pneumococcal andHaemophilus infections during and after therapy. Mild adverse gastrointestinal effects were noticed in five patients.

Key words

Chronic bronchitis Ciprofloxacin Haemophilus influenzae Streptococcus pneumoniae 

References

  1. 1.
    Hoogkamp-Korstanje JAA.In vitro activity of ciprofloxacin. Eur Clin Microbiol 1984;3:333–8.Google Scholar
  2. 2.
    Morel C, Vergnaud M, Langeard MM, Monrocq N. Pefloxacin-diffusion into the bronchial mucus. 13th International Congress of Chemotherapy, Vienna/1983: Proceedings ps 4.6/4–8.Google Scholar
  3. 3.
    Nicki Y, Soejima R, MatsushimaT, Kawanashi M, Nakaha C, Wantanabe M. Clinical studies on DL-8280 in the treatment of patients with respiratory tract infections. Chemotherapy (Tokyo) 1984: 32, supplement, 54–8.Google Scholar
  4. 4.
    Shah PM, Strehl R, Posselt HG, Bender SW. Ciprofloxacin bei Mucoviszidose, eine pharmakokinetische Untersuchung. Fortschr Antimikrobiellen und Antineoplastischen Chemother 1984;3–5:685–90.Google Scholar
  5. 5.
    Bergogne-Berezin E, Berthelot G, Even P, Dennewald G, Stern M. Pharmacokinetics of ciprofloxacin: study of its distribution in the respiratory secretions. 14th International Congress of Chemotherapy, Kyoto, 1985: S40–10.Google Scholar
  6. 6.
    Hoogkamp-Korstanje JAA and Klein S. Ciprofloxacin in acute exacerbations of chronic bronchitis. 14th International Congress of Chemotherapy, Kyoto, 1985: S50–1.Google Scholar
  7. 7.
    Benard Y, Lemenager J, Morel C. Biochemical evaluation of pefloxacin in infectious bronchopulmonary disease. 13th International Congress of Chemotherapy, Vienna, 1983: Proceedings PS 4.6, 4–9.Google Scholar
  8. 8.
    Hoogkamp-Korstanje JAA, Klein SJ. Ciprofloxacin in acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1986;18:407–13.PubMedGoogle Scholar
  9. 9.
    Mehtar S, Drabu YJ. Non-comparative study of ciprofloxacin in respiratory tract infections. 14th International Congress of Chemotherapy, Kyoto 1985: S50–3.Google Scholar
  10. 10.
    Bassaris H, Chrysanthopoulos C, Skoutelis A, Politimakrypoulia V. Treatment of pneumonias with ciprofloxacin. 14th International Congress of Chemotherapy, Kyoto: 1985; p.38–94.Google Scholar
  11. 11.
    Gleadhill IC, Ferguson WP, Lowry RC. Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin. J Antimicrob Chemother 1986;18(Suppl d):133–9.Google Scholar
  12. 12.
    Kobayashi H. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory infection. Am J Med 1987;82:169–74.Google Scholar
  13. 13.
    Honeyboune D, Wise R, Andrews JM. Ciprofloxacin penetration into lungs. Lancet 1987;i:407–13.Google Scholar
  14. 14.
    Schlenkhoff D, Mayer M, Dalhoff A. Penetration of ciprofloxacin into human lung tissue following a simple intravenous administration. 14th International Congress of Chemotherapy, Kyoto, 1985: S40–11.Google Scholar
  15. 15.
    Rubinstein E, Segev S. Drug interactions of ciprofloxacin with other non-antibiotic agents. Am J Med 1987;82:119–23.PubMedGoogle Scholar

Copyright information

© Bohn, Scheltema & Holkema 1987

Authors and Affiliations

  • J. A. A. Hoogkamp-Korstange
    • 1
  • S. J. Klein
    • 2
  1. 1.Laboratory for Public HealthEN Leeuwarden
  2. 2.Department of PulmonologyMedical Centre LeeuwardenCR Leeuwarden

Personalised recommendations